Similar Papers

Paper Title
Journal
Date
Author
In vitro and in vivo evaluation of isoxsuprine loaded invasomes for efficient treatment of diabetes‐accelerated atherosclerosis
Heba A Abou-Taleb ... Fatma I Abo El-Ela
Journal of Drug Delivery Science and Technology | VOL. 96
Heba A Abou-Taleb, et. al.Heba A Abou-Taleb ... Fatma I Abo El-Ela
18 Apr 2024
Functional candesartan loaded lipid nanoparticles for the control of diabetes-associated stroke: In vitro and in vivo studies
Dina M Mahmoud ... Fatma I Abo El-Ela
International Journal of Pharmaceutics: X | VOL. 7
Dina M Mahmoud, et. al.Dina M Mahmoud ... Fatma I Abo El-Ela
02 Jan 2024
Optimization of process parameters for fabrication of electrospun nanofibers containing neomycin sulfate and Malva sylvestris extract for a better diabetic wound healing
Mohammed Monirul Islam ... Nagaraja Sreeharsha
Drug Delivery | VOL. 29
Mohammed Monirul Islam, et. al.Mohammed Monirul Islam ... Nagaraja Sreeharsha
21 Nov 2022
Chapter 19 - Quality by design and formulation optimization using statistical tools for safe and efficient bioactive loading
Madhulika Pradhan ... Manju Rawat Singh
Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents | VOL. -
Madhulika Pradhan, et. al.Madhulika Pradhan ... Manju Rawat Singh
01 Jan 2020
View more papers

More From: National Journal of Pharmaceutical Sciences

Paper Title
Journal
Date
Author
Pharmacokinetic drug-drug interactions: a detailed systematic review
Raj Ahmad Rain ... G Anil K Reddy
National Journal of Pharmaceutical Sciences | VOL. 4
Raj Ahmad Rain, et. al.Raj Ahmad Rain ... G Anil K Reddy
01 Jul 2024
A review on nutritional value, phytoconstituents, therapeutical effect & side effect of super seeds in diet
S Shoba ... T Ramathilaga
National Journal of Pharmaceutical Sciences | VOL. 4
S Shoba, et. al.S Shoba ... T Ramathilaga
01 Jul 2024
-
-
National Journal of Pharmaceutical Sciences | VOL. 4
--
01 Jul 2024
-
-
National Journal of Pharmaceutical Sciences | VOL. 4
--
01 Jul 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.